STRUCTURED ABSTRACT
Importance The emergence of SARS-CoV-2 Variants of Concern (VOC) across North America has been associated with concerns of increased COVID-19 transmission. Characterizing the distribution of VOCs can inform the development and implementation of policies and programs to address the prevention needs of disproportionately affected communities.
Objective We compared per-capita rates of COVID-19 cases (overall and VOC) from February 3, 2021 to March 10, 2021, across neighborhoods in the health regions of Toronto and Peel, Ontario, by proportion of the population working in essential services and income.
Design Descriptive epidemiological analysis, integrating COVID-19 surveillance and census data. Per-capita daily epidemic curves were generated using 7-days rolling averages for cases and deaths. Cumulative per-capita rates were determined using census-reported population of each neighbourhood.
Setting The study setting was the city of Toronto and the region of Peel (the City of Brampton, Mississauga, and Caledon), Canada’s largest cities with a combined population of 4.3 million. This area of Canada has had one of the highest incident rates of COVID-19 throughout the pandemic.
Participants We used person-level data on laboratory-confirmed COVID-19 community cases (N=22,478) and census data for neighborhood-level attributes.
Exposures We stratified neighbourhood using dissemination areas which represent geographic areas of approximately 400-700 individuals, into tertiles by ranking the proportion of population in each neighbourhood working in essential services (health, trades, transport, equipment, manufacturing, utilities, sales, services, agriculture); and the per-person equivalent household income.
Main Outcome(s) and Measure(s) The primary outcomes were laboratory-confirmed COVID-19 cases overall and VOC positives by neighbourhood.
Results During the study period, VOC cases emerged faster in groups with lowest income (growth rate 43.8%, 34.6% and 21.6% by income tertile from lowest to highest), and most essential work (growth rate 18.4%, 30.8% and 50.8% by tertile from lowest tertile of essential workers to highest tertile of essential workers).
Conclusions and Relevance The recent introduction of VOC in the large urban area of Toronto has disproportionately affected neighbourhoods with the most essential workers and lowest income levels. Notably, this is consistent with the increased burden of non-VOC COVID-19 cases suggesting shared risk factors. To date, restrictive public health strategies have been of limited impact in these communities suggesting the need for complementary and well-specified supportive strategies including vaccine prioritization to address disparities and overall incidence of both VOC and non-VOC COVID-19.
Question Does the emergence of Variants of Concern (VOC) in urban centers in Canada affect groups based on income and essential work status disproportionally?
Findings We found a significantly higher cumulative case count and rate of increase of VOC cases amongst those with lowest income and highest essential work status.
Meaning The distribution of VOC and COVID-19 in general is disproportionately distributed, and mitigation measures, including vaccines should be targeted to the highest risk groups.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the Canadian Institutes of Health Research (grant no. VR5-172683).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval The University of Toronto Health Sciences Research Ethics Board (protocol no. 39253) approved the study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We used Case and Contact Management Solutions (CCM)+ person-level data on VOC screen positive cases among laboratory-confirmed COVID-19 cases between February 3rd and March 10, 2021, and the Statistics Canada 2016 Census data for neighbourhood-level characteristics.
